GLP-1 Medications Aid in Reducing Asthma Among Overweight or Obese Teens

Key Research on GLP-1 Drugs and Teen Asthma

Advanced weight-reduction medications, including Ozempic and Zepbound, have the potential to cut severe asthma flare-ups by half in teenagers carrying excess weight, according to a fresh investigation.

The study, published on December 29 in JAMA Network Open, indicated that adolescents prescribed a GLP-1 drug required half the instances of emergency asthma care compared to those not taking such medications.

Leading the research team, Dr. Lin-Shien Fu, head of pediatric nephrology and immunology at Taichung Veterans General Hospital in Taiwan, stated, "Our results indicate a possible twofold advantage for these individuals, as one type of treatment might tackle both weight control and decreased chances of asthma worsening, thus possibly easing the strain of two frequently linked long-term health issues."

Details of the Investigation

Scientists monitored 1,070 children between 12 and 18 years old who were overweight or obese and diagnosed with asthma. Approximately half received a GLP-1 prescription.

These drugs replicate the glucagon-like peptide-1 hormone, aiding in regulating insulin and glucose, curbing hunger, and delaying food breakdown.

Over a year-long tracking period, only eight asthma-linked emergency room trips occurred among those using the GLP-1 medication, in contrast to 19 for the group without it.

Furthermore, teenagers on GLP-1 drugs showed a reduced need for steroid treatments at 21% compared to 31%, and fewer required rescue inhalers, with rates of 32% versus 45%.

Expert Opinions on Weight Reduction and Asthma

Dr. Michelle Katzow, overseeing the POWER Kids Weight Management Program and serving as an associate professor of pediatrics at Cohen Children's Medical Center in New York City, attributed the asthma enhancements to the weight loss achieved by the participants.

She remarked in a press statement, "This outcome isn't unexpected, though the extent of fat reduction from the medication surpasses previous observations." Katzow, who did not participate in the study, explained that excess body weight fuels bodily inflammation, heightening the risk of asthma episodes.

"Inflammation tied to obesity makes individuals prone to more severe asthma or intensified symptoms," she elaborated.

"By enabling sufficient weight reduction through any effective method, asthma severity can improve," she continued.

Role of These Drugs in Lifestyle Challenges

Katzow emphasized that such pharmaceuticals serve best for individuals struggling to embrace healthier habits due to overwhelming hunger.

"This applies to many young people," she noted. "They often feel extremely hungry and fixate on eating constantly, making it tough to opt for nutritious foods or consume fewer calories when appetite is relentless."

Health tracking apps like Shotlee can help monitor weight loss and asthma symptoms in these scenarios, providing valuable insights for ongoing management.